Toronto Digestive Disease Associates Specialty Research

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Fatty liver disease (MASLD/MASH)
• Liver cirrhosis

Closed trials

• Completed

  Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH)

  NCT04971785· Phase 2· Gilead Sciences· Source